CH679152A5 - - Google Patents

Download PDF

Info

Publication number
CH679152A5
CH679152A5 CH172/89A CH17289A CH679152A5 CH 679152 A5 CH679152 A5 CH 679152A5 CH 172/89 A CH172/89 A CH 172/89A CH 17289 A CH17289 A CH 17289A CH 679152 A5 CH679152 A5 CH 679152A5
Authority
CH
Switzerland
Prior art keywords
compound
formula
pharmaceutically acceptable
compounds
purin
Prior art date
Application number
CH172/89A
Other languages
German (de)
English (en)
Inventor
Robert Vince
Mei Hua
Peter Leslie Myers
Richard Storer
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/146,252 external-priority patent/US4916224A/en
Priority claimed from GB888821011A external-priority patent/GB8821011D0/en
Priority claimed from US07/278,652 external-priority patent/US4931559A/en
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of CH679152A5 publication Critical patent/CH679152A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CH172/89A 1988-01-20 1989-01-19 CH679152A5 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/146,252 US4916224A (en) 1988-01-20 1988-01-20 Dideoxycarbocyclic nucleosides
GB888821011A GB8821011D0 (en) 1988-09-07 1988-09-07 Chemical compounds
US07/278,652 US4931559A (en) 1988-01-20 1988-12-05 Optically-active isomers of dideoxycarbocyclic nucleosides

Publications (1)

Publication Number Publication Date
CH679152A5 true CH679152A5 (zh) 1991-12-31

Family

ID=27264063

Family Applications (1)

Application Number Title Priority Date Filing Date
CH172/89A CH679152A5 (zh) 1988-01-20 1989-01-19

Country Status (29)

Country Link
JP (1) JP2793825B2 (zh)
KR (1) KR0127137B1 (zh)
AT (1) AT397801B (zh)
AU (2) AU626278B2 (zh)
BE (1) BE1003815A4 (zh)
CA (1) CA1339896C (zh)
CH (1) CH679152A5 (zh)
DE (1) DE3901502C2 (zh)
DK (1) DK175131B1 (zh)
ES (1) ES2010091A6 (zh)
FI (1) FI93546C (zh)
FR (1) FR2626002B1 (zh)
GB (1) GB2217320B (zh)
GR (1) GR890100033A (zh)
HU (1) HU203755B (zh)
IE (1) IE62275B1 (zh)
IL (1) IL88999A (zh)
IT (1) IT1229531B (zh)
LU (1) LU87437A1 (zh)
MY (1) MY103801A (zh)
NL (1) NL8900122A (zh)
NO (1) NO169123C (zh)
NZ (1) NZ227663A (zh)
OA (1) OA09031A (zh)
PL (1) PL163814B1 (zh)
PT (1) PT89482B (zh)
RU (1) RU2114846C1 (zh)
SE (1) SE505213C2 (zh)
YU (1) YU47791B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
JP3164361B2 (ja) * 1989-06-27 2001-05-08 ザ ウエルカム ファウンデーション リミテッド 治療用ヌクレオシド
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916477D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916480D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5241069A (en) * 1990-04-06 1993-08-31 Glaxo Inc. Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
CN1137274A (zh) * 1993-11-12 1996-12-04 默里尔药物公司 用作免疫抑制剂的6-氧代-核苷
GB9721780D0 (en) 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
DE59905679D1 (de) 1998-10-30 2003-06-26 Lonza Ag Verfahren zur herstellung von 4-[(2',5'-diamino-6'-halogenpyrimidin-4'-yl)amino]-cyclopent-2-enylmethanolen
AU1158000A (en) * 1998-10-30 2000-05-22 Lonza A.G. Method for producing 4- ((2',5'- diamino-6'- halopyrimidine- 4'-YL)amino)- cyclopent- 2-enylmethanols
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
JP7104154B2 (ja) 2018-07-27 2022-07-20 富士フイルム株式会社 シクロペンテニルプリン誘導体またはその塩
WO2021191417A1 (en) 2020-03-27 2021-09-30 Som Innovation Biotech, S.A. Compounds for use in the treatment of synucleinopathies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
JPS62177234A (ja) * 1986-01-30 1987-08-04 Mitsubishi Heavy Ind Ltd 遠心紡糸によるカ−ボン繊維の製造装置
IN164556B (zh) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.

Also Published As

Publication number Publication date
YU47791B (sr) 1996-01-09
SE505213C2 (sv) 1997-07-14
DK23489A (da) 1989-07-21
LU87437A1 (fr) 1989-08-30
GR890100033A (el) 1994-03-31
FI890286A0 (fi) 1989-01-19
GB8901187D0 (en) 1989-03-15
JP2793825B2 (ja) 1998-09-03
NO169123C (no) 1992-05-13
AT397801B (de) 1994-07-25
FI890286A (fi) 1989-07-21
NL8900122A (nl) 1989-08-16
BE1003815A4 (fr) 1992-06-23
AU2867189A (en) 1989-07-20
DE3901502C2 (de) 2002-06-13
FI93546B (fi) 1995-01-13
HU203755B (en) 1991-09-30
YU12389A (en) 1991-10-31
AU1018092A (en) 1992-03-12
PL163814B1 (en) 1994-05-31
CA1339896C (en) 1998-06-02
DE3901502A1 (de) 1989-07-27
NO890253D0 (no) 1989-01-19
IT8947546A0 (it) 1989-01-19
FI93546C (fi) 1995-04-25
ES2010091A6 (es) 1989-10-16
ATA10689A (de) 1993-11-15
IT1229531B (it) 1991-09-04
NO169123B (no) 1992-02-03
FR2626002A1 (fr) 1989-07-21
HUT48887A (en) 1989-07-28
SE8900192D0 (sv) 1989-01-19
AU637015B2 (en) 1993-05-13
SE8900192L (sv) 1989-07-21
KR0127137B1 (ko) 1997-12-29
IE62275B1 (en) 1995-01-25
KR890011902A (ko) 1989-08-23
JPH02196788A (ja) 1990-08-03
IL88999A0 (en) 1989-08-15
OA09031A (en) 1991-03-31
IE890153L (en) 1989-07-20
PT89482A (pt) 1989-10-04
PT89482B (pt) 1994-02-28
FR2626002B1 (fr) 1994-01-28
GB2217320A (en) 1989-10-25
NZ227663A (en) 1990-09-26
NO890253L (no) 1989-07-21
MY103801A (en) 1993-09-30
RU2114846C1 (ru) 1998-07-10
DK175131B1 (da) 2004-06-14
GB2217320B (en) 1992-04-08
AU626278B2 (en) 1992-07-30
PL277261A1 (en) 1989-09-18
IL88999A (en) 1994-12-29
DK23489D0 (da) 1989-01-19

Similar Documents

Publication Publication Date Title
AT397801B (de) Didesoxydehydrocarbocyclische nucleoside und deren verwendung
DE69232845T2 (de) 1,3-Oxathiolannukleosid-analoge Verbindungen
DE68921798T2 (de) Therapeutische Nuleoside.
DE3689976T2 (de) Therapeutische Nucleoside und deren Herstellung.
DE69033197T2 (de) Therapeutische Nukleoside
US4916224A (en) Dideoxycarbocyclic nucleosides
DE69026971T2 (de) Substituierte 1,3-Oxathiolane mit antiviraler Wirkung
EP1049695B1 (de) 2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren
FI111722B (fi) Menetelmä valmistaa cis-4-amino-1-(2-hydroksimetyyli-1,3-oksatiolan-5-yyli)-(1H)-pyrimidin-2-onin (-)-enantiomeeriä käytettäväksi virustenvastaisena aineena
DE69330274T2 (de) Enantiomerisch reine beta-d-dioxolan-nukleoside
DE69122264T2 (de) Substituierte 1,3-oxathiolane mit antiviralen eigenschaften
DE69716924T2 (de) Phosphonat-nukleotid-verbindungen
DE2539963A1 (de) Purinverbindungen und ihre salze, sowie verfahren zu ihrer herstellung
DE3852710T2 (de) Therapeutische Nukleoside.
DE69313872T2 (de) Verbindung von nucleocidanaloga zur behandlung viraler infektionen
US4950758A (en) Optically-active isomers of dideoxycarbocyclic nucleosides
DE68903226T2 (de) Dideoxydidehydrocarbocyclische nukleoside.
AU627188B2 (en) Pharmaceutical products
DE3875769T2 (de) Therapeutische nukleoside.
JPS6087298A (ja) プリン及びピリミジン非環式ヌクレオシドの環状ピロホスフエート
DE3650384T2 (de) Antivirale Purin-Derivate und Verfahren zu ihrer Herstellung.
DE3854811T2 (de) Anti-HIV Pyrimidin Nucleoside
EP0217207A1 (de) In 6- und 9-Stellung substituierte 2-Aminopurine, ihre Verwendung, diese Purine enthaltende Arzneimittel und Verfahren zur Herstellung der Purine
DE69231242T2 (de) Als Immunosuppressiva nützliche Trans-Cyclopentanylpurinanaloge
DE69118016T2 (de) Cyclobutan-Derivate

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: REGENTS OF THE UNIVERSITY OF MINNESOTA

Free format text: REGENTS OF THE UNIVERSITY OF MINNESOTA#100 CHURCH STREET SOUTHEAST#MINNEAPOLIS/MN (US) -TRANSFER TO- REGENTS OF THE UNIVERSITY OF MINNESOTA#100 CHURCH STREET SOUTHEAST#MINNEAPOLIS/MN (US)

PL Patent ceased